Athyrium Capital Management, LP Amryt Pharma PLC Transaction History

Athyrium Capital Management, LP

  • $3.2 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
BUY
$7.0 - $14.77 $62 Million - $131 Million
8,857,268 New
8,857,268 $129 Million
Q1 2023

May 15, 2023
SELL
$7.0 - $14.77 $62 Million - $131 Million
-8,857,268 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$9.44 - $12.24 $40.9 Million - $53.1 Million
4,337,268 Added 95.96%
8,857,268 $95.7 Million
Q4 2020

Feb 16, 2021
BUY
$12.22 - $14.16 $55.2 Million - $64 Million
4,520,000 New
4,520,000 $64 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Athyrium Capital Management, LP Portfolio

Follow Athyrium Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athyrium Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athyrium Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email